Filter
5938
Filtered Results: 5938
Text search:
medication
Featured
Recommendations
585
New Publications
1358
Language
Document type
No document type
3131
Studies & Reports
1002
Guidelines
807
Manuals
369
Strategic & Response Plan
182
Fact sheets
156
Training Material
141
Situation Updates
44
Brochures
39
Infographics
37
Resource Platforms
18
Online Courses
6
Videos
5
App
1
Countries / Regions
Global
272
India
253
South Africa
158
Kenya
152
Ethiopia
114
Western and Central Europe
112
Africa
99
Nigeria
93
Uganda
90
Sierra Leone
89
Nepal
88
Liberia
80
Ukraine
79
Tanzania
77
Zambia
77
Malawi
73
Ghana
71
Rwanda
65
Bangladesh
61
Latin America and the Carribbean
60
Syria
59
Myanmar / Burma
54
Germany
52
Philippines
49
Congo, Democratic Republic of
49
Namibia
43
South–East Asia Region
40
Eastern Europe
36
Zimbabwe
35
West and Central Africa
34
Lesotho
33
East and Southern Africa
32
Asia
31
Indonesia
31
Middle East and North Africa
29
South Sudan
28
Cambodia
26
Venezuela
26
Mozambique
25
Haiti
25
Russia
24
Burkina Faso
23
Guinea
22
Botswana
22
Cameroon
21
Eastern Europe and Central Asia
20
Yemen
19
Senegal
18
Brazil
17
Afghanistan
16
Jordan
16
Benin
15
Colombia
14
Thailand
14
USA
14
Western Pacific Region
14
Lebanon
14
Vietnam
14
Pakistan
14
Eswatini/ Swaziland
13
Tajikistan
12
Sudan
12
Central African Republic
12
Laos
10
Argentina
10
China
9
Albania
9
Moldova
9
Somalia
9
Paraguay
8
Sri Lanka
8
Mali
8
Chile
7
Peru
7
Palestine
7
Georgia
7
Iraq
7
Madagascar
7
Iran
6
Côte d’Ivoire / Ivory Coast
6
Mexico
5
Serbia
5
Kyrgyzstan
5
North America
5
United Kingdom
5
Papua New Guinea
5
Libya
5
Ecuador
5
North Macedonia
4
Kazakhstan
4
Canada
4
Morocco
4
Jamaica
4
Spain
4
Southern Africa
4
Bolivia
4
Chad
4
Bhutan
4
Timor Leste/ East Timor
3
Turkey
3
Estonia
3
Niger
3
Burundi
3
Malaysia
3
Guinea-Bissau
3
Saudi Arabia
3
Japan
3
Egypt
3
Romania
3
Angola
3
Guatemala
3
Gambia
2
Togo
2
Fiji
2
Mongolia
2
Bulgaria
2
Armenia
2
Hungary
2
Lithuania
2
Turkmenistan
2
Tunisia
2
Portugal
2
Azerbaijan
2
Belarus
2
Djibouti
2
Greece
2
Poland
2
North Korea
1
Switzerland
1
El Salvador
1
Australia
1
Singapore
1
Uzbekistan
1
Qatar
1
Croatia
1
Ireland
1
Gabon
1
Denmark
1
Mauritius
1
Norway
1
South Korea
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Slovakia
1
Solomon Islands
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Countries
1944
Clinical Guidelines
576
Public Health
411
Women & Child Health
325
Key Resources
184
Capacity Building
167
Pharmacy & Technologies
56
Annual Report MEDBOX
2
Toolboxes
Mental Health
728
HIV
463
COVID-19
443
TB
335
Caregiver
253
NCDs
242
Disability
202
AMR
199
Refugee
186
Conflict
155
Planetary Health
143
Pharmacy
139
NTDs
139
Ebola
129
Rapid Response
128
Global Health Education
76
Natural Hazards
46
Social Ethics
30
Zika
27
Specific Hazards
22
Health Financing Toolbox
22
Polio
21
Cholera
19
South Sudan
1
Health Financing
1
Typhoon
1
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
This report presents key findings from a study carried out on ‘Assessing the effectiveness of targeting mechanisms under PMJAY’. It provides a detailed analysis of potential inclusion and exclusion errors in two select states in India (Haryana and Uttarakhand) to inform National Health Authority...
This report presents key findings from a study on ‘assessing the effectiveness of targeting mechanisms under PMJAY’. It provides a detailed analysis of potential inclusion and exclusion errors in two select states in India (Haryana and Uttarakhand) to inform National Health Authority’s (NHA) p...
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation and certification across PMJAY empanelled hospitals from three diffe...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
January 2020 to December 2021
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
The executive summary of the WHO Global oral health status report presents a snapshot of the most recent data on major oral diseases, risk factors, health system challenges and opportunities for reform. The report’s clear conclusion is that the status of global oral health is alarming and requires...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
